Geospiza Adds Montgomery to Board

10/19/10Follow @xconomy

Geospiza, the Seattle-based maker of software for biological analysis, is announcing today that veteran drug developer Bruce Montgomery is joining its board of directors. Montgomery recently stepped down as senior vice president of respiratory drugs at Gilead Sciences, four years after he sold Seattle-based Corus Pharma to Gilead for $365 million. Geospiza’s chairman, Gordon Gardiner, said Montgomery will add expertise to the board as the company seeks to grow beyond its traditional base of academic research customers, and expand more into pharmaceutical R&D.

By posting a comment, you agree to our terms and conditions.